NCBI . NLM . NIH . GOV {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Ncbi.nlm.nih.gov Make Money
Keywords
Topics
Questions
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC3800143/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC3800143/. The analysis below is for the second page.

Title[redir]:
Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy? - PMC
Description:
Pancreatic cancer, due to its late diagnosis, is difficult to treat. In addition, current therapy options are insufficient and new approaches for combination treatment are required. Recent demonstration of the importance of constitutive signaling of ...

Matching Content Categories {📚}

Health & Fitness
Science
Education

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 6,398,976 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We're unsure how the site profits.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Ncbi.nlm.nih.gov might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

nik, doi, cancer, nfκb, pancreatic, pathway, kinase, traf, alternative, inhibitors, pubmed, google, scholar, pmc, target, cells, cell, signaling, article, activation, expression, canonical, free, targeting, activity, ikkα, degradation, levels, proliferation, strategy, nlm, pathways, increased, multiple, shown, inhibit, therapy, approaches, combination, apoptosis, inhibitor, active, domain, pdac, myeloma, specific, inhibition, ncbi, search, rev,

Topics {✒️}

nf-κ b-inducing kinase traf2-nik-nf-κb2 signaling pathway nf-κb-inducing kinase regulates p52/relb nf-κb heterodimer inhibiting nf-κb-inducing kinase nf-κb-inducing kinase �nf-κb-inducing kinase nf-κb inducing kinase noncanonical nf-κb pathway nuclear factor-κb inhibitor alternative nf-κb pathway lymphotoxin-β receptor ltβ nik/nf-κb2 pathway nf-κb2 p100 pmc beta search prevent stimulus-dependent degradation canonical nf-κb pathway suppresses nf-κb activation alternative nf-κb pathways disrupt hsp90/cdc37 complex ikkα controls p52/relb inhibit nf-κb due nf-κb signaling nf-κb subunits enhance bortezomib-induced apoptosis inhibit nf-κb nf-κb pathways pancreatic ductal adenocarcinoma flexible active site κb kinase complex �nf-κb’ inhibitors inhibits nf-κb license information pmcid page abstract introduction mol cancer ther year view regulates antiapoptotic signaling kinase domain reveals pancreatic intraepithelial neoplasia human prostate cancer cancer biol ther basally active kinase active kinase complex cell permeable peptides broad spectrum inhibitor iκb kinase α serine/threonine kinase dominant-active mutant constitutively active conformation publisher site pdf

Questions {❓}

Is NF-κB a good target for cancer therapy?
Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?

Social Networks {👍}(6)

External Links {🔗}(61)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager

Libraries {📚}

jQuery
jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

nihcesxway.hub.nih.gov
nihcesxway2.hub.nih.gov
nihcesxway3.hub.nih.gov
nihcesxway4.hub.nih.gov
nihcesxway5.hub.nih.gov

Name Servers:

dns1-ncbi.ncbi.nlm.nih.gov
dns2-ncbi.ncbi.nlm.nih.gov
lhcns1.nlm.nih.gov
lhcns2.nlm.nih.gov

CDN Services {📦}

Ncbi

3.51s.